Login
$RENEF
$12.71 +$0.00 (0.0%) Close

Balance sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
ASSETS
Current assets
Cash
Prepaid expenses
Total Current assets
Interest-bearing Demand Deposit held in Trust Account
TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS' DEFICIT
Current liabilities
Accrued expenses
Promissory note - related party
Total Current liabilities
Warrant liabilities
Convertible promissory notes - related party, at fair value
Deferred underwriting fee
TOTAL LIABILITIES
Class A ordinary shares subject to possible redemption; 3,076,094 shares at redemption value of approximately $12.48 and $12.33 per share as of June 30, 2026 and December 31, 2025, respectively
Class A Ordinary Shares Subject to Possible Redemption
SHAREHOLDERS' DEFICIT
Ordinary shares
Accumulated deficit
TOTAL SHAREHOLDERS' DEFICIT
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support